192 related articles for article (PubMed ID: 31845753)
1. [ABC transporters and drug resistance in epilepsy: biological plausibility, pharmacogenetics and precision medicine].
Riquelme-Alcázar J; González-Vargas R; Moya PR
Rev Neurol; 2020 Jan; 70(1):23-32. PubMed ID: 31845753
[TBL] [Abstract][Full Text] [Related]
2. Clinical reappraisal of the influence of drug-transporter polymorphisms in epilepsy.
Orlandi A; Paolino MC; Striano P; Parisi P
Expert Opin Drug Metab Toxicol; 2018 May; 14(5):505-512. PubMed ID: 29804481
[TBL] [Abstract][Full Text] [Related]
3. Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.
Soranzo N; Kelly L; Martinian L; Burley MW; Thom M; Sali A; Kroetz DL; Goldstein DB; Sisodiya SM
Epilepsia; 2007 Apr; 48(4):674-83. PubMed ID: 17437410
[TBL] [Abstract][Full Text] [Related]
4. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
[TBL] [Abstract][Full Text] [Related]
5. Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy.
Xiong J; Mao DA; Liu LQ
Biomed Res Int; 2015; 2015():194541. PubMed ID: 26491660
[TBL] [Abstract][Full Text] [Related]
6. [ABC transporters' impact on effect and metabolism of drugs].
Slåtsve AM; Ravna AW; Lyså RA; Sager G
Tidsskr Nor Laegeforen; 2011 Jun; 131(11):1084-7. PubMed ID: 21681236
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition.
Haufroid V
Curr Drug Targets; 2011 May; 12(5):631-46. PubMed ID: 21039333
[TBL] [Abstract][Full Text] [Related]
8. ABC transporters in drug-refractory epilepsy: limited clinical significance of pharmacogenetics?
Cascorbi I
Clin Pharmacol Ther; 2010 Jan; 87(1):15-8. PubMed ID: 20019695
[No Abstract] [Full Text] [Related]
9. Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.
Lepper ER; Nooter K; Verweij J; Acharya MR; Figg WD; Sparreboom A
Pharmacogenomics; 2005 Mar; 6(2):115-38. PubMed ID: 15882131
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy.
Kim DW; Lee SK; Chu K; Jang IJ; Yu KS; Cho JY; Kim SJ
Epilepsy Res; 2009 Mar; 84(1):86-90. PubMed ID: 19167193
[TBL] [Abstract][Full Text] [Related]
11. ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?
Bruckmueller H; Cascorbi I
Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):369-396. PubMed ID: 33459081
[TBL] [Abstract][Full Text] [Related]
12. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
Löscher W; Luna-Tortós C; Römermann K; Fedrowitz M
Curr Pharm Des; 2011; 17(26):2808-28. PubMed ID: 21827408
[TBL] [Abstract][Full Text] [Related]
13. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
14. Ontogeny of ABC and SLC transporters in the microvessels of developing rat brain.
Soares RV; Do TM; Mabondzo A; Pons G; Chhun S
Fundam Clin Pharmacol; 2016 Apr; 30(2):107-16. PubMed ID: 26662930
[TBL] [Abstract][Full Text] [Related]
15. ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis.
Haerian BS; Roslan H; Raymond AA; Tan CT; Lim KS; Zulkifli SZ; Mohamed EH; Tan HJ; Mohamed Z
Seizure; 2010 Jul; 19(6):339-46. PubMed ID: 20605481
[TBL] [Abstract][Full Text] [Related]
16. ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches.
Leandro K; Bicker J; Alves G; Falcão A; Fortuna A
Pharmacol Res; 2019 Jun; 144():357-376. PubMed ID: 31051235
[TBL] [Abstract][Full Text] [Related]
17. Impact of variants in ATP-binding cassette transporters on breast cancer treatment.
Xiao Q; Zhou Y; Lauschke VM
Pharmacogenomics; 2020 Dec; 21(18):1299-1310. PubMed ID: 33222659
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.
Bruhn O; Cascorbi I
Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
Löscher W; Potschka H
NeuroRx; 2005 Jan; 2(1):86-98. PubMed ID: 15717060
[TBL] [Abstract][Full Text] [Related]
20. [Personalized medicine for epilepsy based on the pharmacogenomic testing].
Yoshida S; Sugawara T; Nishio T; Kaneko S
Brain Nerve; 2011 Apr; 63(4):295-9. PubMed ID: 21441631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
